Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Taxus Cardium Pharmaceuticals Group Inc.

Latest From Applied Catheter Technologies Inc.

Start-Up Quarterly Statistics, Q4 2008

Highlights from the Q4 2008 review of start-up dealmaking: Fundraising in the biopharma, med-device, and in vitro diagnostics industries totaled $551 million, a 41% decrease from 3Q and just another indication of the tough economic times. Of the three acquisitions done this quarter--two in biopharma and one in devices--only one had a disclosed value. About one-third of the 19 biopharma alliances were in the cancer therapy area.
BioPharmaceutical Medical Device

Selected Start-Ups

In Vivo briefly describes these recently founded companies: AgileNano, Applied Catheter Technologies, Coromedic, EpiTherapeutics, GPC-Rx and RCP Therapeutics.
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Musculoskeletal & Connective Tissue Disorders
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Cardium Therapeutics Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Taxus Cardium Pharmaceuticals Group Inc.
  • Senior Management
  • Christopher J Reinhard, Chmn., Pres. & CEO
    Gabor M Rubanyi, MD, PhD, CSO
  • Contact Info
  • Taxus Cardium Pharmaceuticals Group Inc.
    Phone: (858) 436-1000
    11750 Sorrento Valley Rd., Ste. 250
    San Diego, CA 92121